{"url_path":"/sec/bdtb/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/2041531/0001829126-26-005192-index.html","accession_number":"0001829126-26-005192","cik":"0002041531","ticker":"BDTB","issuer_name":"Bodhi Tree Biotechnology Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/2041531/0001829126-26-005192-index.html","primary_entity_key":"0002041531","primary_entity_name":"Bodhi Tree Biotechnology Inc"},"word_count":240,"has_tables":true,"body_markdown":"**Item 6. Exhibits**\n\n \n\n**Exhibit No.**\n \n**Description**\n\n31.1\n \n[Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](bodhitreebiotech_ex31-1.htm)\n\n31.2\n \n[Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](bodhitreebiotech_ex31-2.htm)\n\n32.1\n \n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](bodhitreebiotech_ex32-1.htm)\n\n32.2\n \n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](bodhitreebiotech_ex32-2.htm)\n\n101.INS*\n \nInline XBRL Instance Document\n\n101.SCH*\n \nInline XBRL Taxonomy Extension Schema Document\n\n101.CAL*\n \nInline XBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF*\n \nInline XBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB*\n \nInline XBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE*\n \nInline XBRL Taxonomy Extension Presentation Linkbase Document\n\n104\n \nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n \n\n19\n\n \n\n \n\n**SIGNATURES**\n\n \n\nIn accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\nDate: May 14, 2026\n\n \n\n \n**Bodhi Tree Biotechnology Inc.**\n\n \n \n \n\n \nBy:\n/s/ Xiaohang Wang\n\n \nName:\nXiaohang Wang\n\n \nTitle:\nChief Executive Officer and Chairman\n\n \n \n(Principal Executive Officer)\n\n \n\n \n**Bodhi Tree Biotechnology Inc.**\n\n \n \n \n\n \nBy:\n/s/ Juan Ye\n\n \nName:\nJuan Ye\n\n \nTitle:\nChief Financial Officer\n\n \n \n(Principal Accounting and Financial Officer)\n\n \n\n20"}